Login to Your Account

BioInvent, Servier Ink $14M Antibody Discovery Deal

By Cormac Sheridan
BioWorld International Correspondent

Wednesday, January 11, 2012
BioInvent International AB could earn up to €11 million (US$14 million) in up-front and milestone payments, as well as royalties on eventual product sales, from a cancer antibody discovery collaboration with Les Laboratoires Servier SA.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription